Why Should You Attend:
Each person engaged in the manufacture, processing, packing, or holding of a drug product shall have training in the current good manufacturing practice (cGMP) regulations and written procedures required by these regulations as they relate to the employee’s functions. Training in cGMP shall be conducted by qualified individuals on a continuing basis and with sufficient frequency to assure that employees remain familiar with cGMP requirements applicable to them.
This webinar will explain cGMP regulations as it relates to the learner’s particular job. Attendees will learn how to apply the principles of cGMP to enhance the compliance culture of the learner’s company.
Areas Covered in the Webinar:
Who will benefit:
Philip Russ, is an experienced quality/compliance professional with 20 years’ experience in the pharmaceutical, medical device and biologics industry. He has a record of success developing and managing quality systems to support these businesses.
He has a breadth of experience performing/coordinating compliance audits involving CFR210/211, CFR820, ISO13485, QSR/PAL and CMDCAS regulations.
Mr. Russ has provided expert counsel in quality systems for early development projects; pioneering drug/medical device/drug combo quality systems and compliance initiatives; designing statistical and attribute analysis programs for manufacturing processes; continuous improvement, auditing, supplier quality management, technology transfer and validation support; statistical process controls; QA expertise for development activities, design controls and GCP for both medical device and drug products.
Mr. Russ is the owner and principal consultant of ICGXP. ICGXP offers a range of regulatory compliance and quality assurance services. Inspection readiness is an expertise that Mr. Russ and his team of associates provide clients to benefit their compliance profile and foster success in the market place.
cGMPs are regulations published by the FDA to provide criteria for complying with the Federal Food, Drug, and Cosmetic Act (FD&C Act) and requires that all drug products that are developed and produced are safe, properly identified, of the correct quality, strength, and purity.
Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
PAYMENT METHOD: 100% Secure Transaction